COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS

Inventories

Inventories, net, consisted of the following (in thousands):



	June 30, 2014		December 31, 2013
Raw materials	$	7,893	$	4,132
Work in process	4,481		1,696
Finished goods	13,605		3,648
	$	25,979	$	9,476

Inventories at June 30, 2014 included $14.9 million of inventories acquired from AngioScore. See Note 2, “Business Combination,” for further discussion.

Property and Equipment

Property and equipment, net, consisted of the following (in thousands):



	June 30, 2014			December 31, 2013
Equipment held for rental or loan	$	44,342		$	42,949
Manufacturing equipment and computers	29,845			24,827
Leasehold improvements	6,536			5,697
Furniture and fixtures	3,257			2,446
Building and improvements	1,276			1,276
Land	270			270
Less: accumulated depreciation and amortization	(54,992		)	(49,184		)
	$	30,534		$	28,281

Property and equipment at June 30, 2014 included $0.7 million of property and equipment acquired from AngioScore. See Note 2, “Business Combination,” for further discussion.

Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):



	June 30, 2014			December 31, 2013
Accrued payroll and employee-related expenses	$	12,709		$	11,007
Accrued transaction costs	2,050			—
Accrued sales, income, and excise taxes	1,522			1,659
Accrued clinical study expense	1,239			872
Deferred rent	1,172			1,204
Accrued legal costs	1,056			134
Employee stock purchase plan liability	900			801
Accrued royalties	669			571
Contingent consideration, current portion	500			500
Accrued interest on convertible notes	453			—
Other accrued expenses	5,483			3,286
Less: long-term portion	(1,195		)	(1,215		)
Accrued liabilities: current portion	$	26,558		$	18,819

Accrued liabilities at June 30, 2014 included $3.3 million of accrued liabilities acquired from AngioScore. See Note 2, “Business Combination,” for further discussion.